PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

被引：0

作者：

Perez-Larraya, J. Gallego ^{[1
]}

Garcia-Moure, M. ^{[2
]}

Gonzalez-Huarriz, M. ^{[2
]}

Zalacain, M. ^{[2
]}

Marrodan, L. ^{[2
]}

Puigdelloses, M. ^{[2
]}

Labiano, S.

de la Nava, D. ^{[2
]}

Laspidea, V. ^{[2
,3
]}

Ausejo, I. ^{[2
]}

Hervas, I. ^{[2
]}

Esparragosa, I. ^{[1
]}

Giraldez, M. ^{[1
]}

Dominguez, P. ^{[1
]}

Martinez-Simon, A. ^{[1
]}

Idoate, M. ^{[1
]}

Fueyo, J. ^{[4
]}

Gomez-Manzano, C. ^{[4
]}

Patino, A. ^{[1
]}

Diez-Valle, R. ^{[5
]}

Tejada, S. ^{[5
]}

Alonso, M.

机构：

[1] Clin Univ Navarra, Pamplona, Spain

[2] Ctr Appl Med Res, Pamplona, Spain

[3] Univ Navarra, Pamplona, Spain

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[5] Quiron Hosp, Madrid, Spain

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad137.404

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P17.14.B

引用

页码：120 / 120

页数：1

共 50 条

[1] A PHASE I STUDY OF THE ONCOLYTIC VIRUS DNX-2401 AND A SHORT COURSE TEMOZOLOMIDE FOR GLIOBLASTOMA AT FIRST RECURRENCE
Tejada, Sonia
Diez Valle, Ricardo
Gallego, Jaime
Alonso, Marta M.
Peterkin, Joana
NEURO-ONCOLOGY, 2016, 18 : 4 - 4
[2] THE ONCOLYTIC ADENOVIRUS DNX-2401 HAS ANTITUMOR ACTIVITY IN GLIOBLASTOMA
不详
CANCER DISCOVERY, 2018, 8 (04) : 382 - 382
[3] Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri
Vikas Patil
Leeor S. Yefet
Olivia Singh
Jeff Liu
Rachel M. A. Dang
Takafumi N. Yamaguchi
Mariza Daras
Timothy F. Cloughesy
Howard Colman
Priya U. Kumthekar
Clark C. Chen
Robert Aiken
Morris D. Groves
Shirley S. Ong
Rohan Ramakrishna
Michael A. Vogelbaum
Simon Khagi
Thomas Kaley
Jason M. Melear
David M. Peereboom
Analiz Rodriguez
Maxim Yankelevich
Suresh G. Nair
Vinay K. Puduvalli
Kenneth Aldape
Andrew Gao
Álvaro López-Janeiro
Carlos E. de Andrea
Marta M. Alonso
Paul Boutros
Joan Robbins
Warren P. Mason
Adam M. Sonabend
Roger Stupp
Juan Fueyo
Candelaria Gomez-Manzano
Frederick F. Lang
Gelareh Zadeh
Nature Medicine, 2023, 29 : 1370 - 1378
[4] ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL
Nassiri, Farshad
Patil, Vikas
Yefet, Leeor
Singh, Olivia
Liu, Jeff
Dang, Rachel
Yamaguchi, Takafumi
Daras, Mariza
Cloughesy, Timothy
Colman, Howard
Kumthekar, Priya
Chen, Clark
Aiken, Robert
Groves, Morris
Ong, Shirley
Ramakrishna, Rohan
Vogelbaum, Michael A.
Khagi, Simon
Kaley, Thomas
Melear, Jason
Peereboom, David
Rodriguez, Analiz
Yankelevich, Maxim
Nair, Suresh
Puduvalli, Vinay
Aldape, Kenneth
Gao, Andrew
Lopez-Janeiro, Alvaro
de Andrea, Carlos
Alonso, Marta
Boutros, Paul
Robbins, Joan
Mason, Warren
Sonaben, Adam
Stupp, Roger
Fueyo-Margareto, Juan
Gomez-Manzano, Candelaria
Lang, Frederick
Zadeh, Gelareh
NEURO-ONCOLOGY, 2023, 25
[5] Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nassiri, Farshad
Patil, Vikas
Yefet, Leeor S.
Singh, Olivia
Liu, Jeff
Dang, Rachel M. A.
Yamaguchi, Takafumi N.
Daras, Mariza
Cloughesy, Timothy F.
Colman, Howard
Kumthekar, Priya U.
Chen, Clark C.
Aiken, Robert
Groves, Morris D.
Ong, Shirley S.
Ramakrishna, Rohan
Vogelbaum, Michael A.
Khagi, Simon
Kaley, Thomas
Melear, Jason M.
Peereboom, David M.
Rodriguez, Analiz
Yankelevich, Maxim
Nair, Suresh G.
Puduvalli, Vinay K.
Aldape, Kenneth
Gao, Andrew
Lopez-Janeiro, Alvaro
de Andrea, Carlos E.
Alonso, Marta M.
Boutros, Paul
Robbins, Joan
Mason, Warren P.
Sonabend, Adam M.
Stupp, Roger
Fueyo, Juan
Gomez-Manzano, Candelaria
Lang, Frederick F.
Zadeh, Gelareh
NATURE MEDICINE, 2023, 29 (06) : 1370 - +
[6] Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: Clinical data and prognostic biomarkers
Alonso, Marta M.
Garcia-Moure, Marc
Gonzalez-Huarriz, Marisol
Marigil, Miguel
Hernandez-Alcoceba, Ruben
Bunales, Maria
Hervas, Sandra
Gallego, Jaime
Gomez-Manzano, Candelaria
Fueyo, Juan
Lang, Frederick
Peterkin, Joanna
Diez-Valle, Ricardo
Tejada, Sonia
CANCER RESEARCH, 2017, 77
[7] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
Inigo-Marco, Ignacio
Diez-Valle, Ricardo
Garcia-Moure, Marc
Patino-Garcia, Ana
Gonzalez Huarriz, Marisol
Jones, Chris
Gomez-Manzano, Candelaria
Fueyo, Juan
Alonso, Marta M.
Tejada, Sonia
NEURO-ONCOLOGY, 2019, 21 : 283 - 284
[8] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
Alonso, M. M.
Inigo, I.
Gonzalez-Huarriz, M.
Dominguez, P.
Patino, A.
Jones, C.
Gomez-Manzano, C.
Fueyo, J.
Diez-Valle, R.
Tejada, S.
NEURO-ONCOLOGY, 2019, 21 : 11 - 11
[9] ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
Inigo-Marco, Ignacio
Gonzalez-Huarriz, Marisol
Garcia-Moure, Marc
Tamayo, Ibon
Hervas, Sandra
Hernandez, Ruben
Bunales, Maria
DeAndrea, Carlos
Villalba, Maria
Jones, Chris
MacKay, Alan
Hulleman, Esther
Van der Lugt, Jasper
Aldave, Guillermo
Lopez-Ibor, Blanca
Patino-Garcia, Ana
Diez-Valle, Ricardo
Fueyo, Juan
Gomez-Manzano, Candelaria
Gallego Perez de Larraya, Jaime
Tejada, Sonia
Alonso, Marta M.
NEURO-ONCOLOGY, 2020, 22 : 473 - 473
[10] STEM CELL DELIVERY OF ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWING SURGICAL RESECTION FOR THE TREATMENT OF GLIOBLASTOMA
Gopakumar, Sricharan
Gumin, Joy
Daou, Marc
Ledbetter, Daniel
McDonald, Malcolm
Hossain, Anwar
Hingtgen, Shawn
Ewend, Matthew
Lang, Frederick
NEURO-ONCOLOGY, 2019, 21 : 95 - 95

← 1 2 3 4 5 →